X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16246) 16246
Newsletter (196) 196
Magazine Article (27) 27
Book Chapter (21) 21
Newspaper Article (16) 16
Dissertation (9) 9
Reference (4) 4
Book / eBook (2) 2
Book Review (2) 2
Conference Proceeding (2) 2
Publication (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13915) 13915
bacteremia (9118) 9118
male (8508) 8508
female (7831) 7831
infectious diseases (6347) 6347
middle aged (5655) 5655
anti-bacterial agents - therapeutic use (5608) 5608
bacteremia - drug therapy (5465) 5465
bacteremia - microbiology (5000) 5000
adult (4879) 4879
aged (4833) 4833
microbiology (4581) 4581
infections (3618) 3618
mortality (3150) 3150
risk factors (3026) 3026
retrospective studies (2892) 2892
antibiotics (2571) 2571
treatment outcome (2556) 2556
microbial sensitivity tests (2477) 2477
adolescent (2278) 2278
aged, 80 and over (2221) 2221
anti-bacterial agents - pharmacology (2194) 2194
health aspects (2075) 2075
pharmacology & pharmacy (2002) 2002
epidemiology (1983) 1983
immunology (1959) 1959
bacteremia - epidemiology (1924) 1924
child (1905) 1905
infection (1820) 1820
sepsis (1807) 1807
bacteremia - diagnosis (1795) 1795
staphylococcal infections - drug therapy (1731) 1731
child, preschool (1671) 1671
infant (1631) 1631
therapy (1557) 1557
research (1553) 1553
risk-factors (1537) 1537
staphylococcus aureus (1429) 1429
pediatrics (1359) 1359
care and treatment (1339) 1339
blood (1336) 1336
prospective studies (1320) 1320
medicine, general & internal (1298) 1298
vancomycin (1283) 1283
staphylococcal infections - microbiology (1270) 1270
bacteremia - mortality (1268) 1268
bacteremia - etiology (1265) 1265
animals (1262) 1262
anti-bacterial agents - administration & dosage (1248) 1248
pneumonia (1194) 1194
hospitals (1191) 1191
drug resistance, bacterial (1178) 1178
bacteria (1168) 1168
diagnosis (1162) 1162
infant, newborn (1129) 1129
endocarditis (1128) 1128
bacteremia - complications (1127) 1127
blood-stream infections (1119) 1119
drug resistance (1099) 1099
cross infection - microbiology (1084) 1084
children (1077) 1077
young adult (1076) 1076
drug resistance in microorganisms (1068) 1068
nosocomial infections (1063) 1063
internal medicine (1042) 1042
analysis (1041) 1041
infectious disease (1001) 1001
management (999) 999
incidence (994) 994
patients (972) 972
drug therapy (945) 945
cross infection - drug therapy (941) 941
resistance (900) 900
impact (887) 887
prognosis (843) 843
medicine (807) 807
research article (794) 794
cross infection - epidemiology (790) 790
staphylococcus aureus - drug effects (788) 788
prevalence (773) 773
time factors (767) 767
cohort studies (762) 762
cancer (755) 755
oncology (745) 745
gram-negative bacterial infections - drug therapy (739) 739
fever (736) 736
gram-positive bacterial infections - drug therapy (728) 728
outcomes (726) 726
drug therapy, combination (725) 725
medical research (725) 725
pathogens (725) 725
vancomycin - therapeutic use (718) 718
drug resistance, multiple, bacterial (704) 704
surgery (700) 700
antimicrobial resistance (692) 692
septic shock (688) 688
prevention (673) 673
drug resistance, microbial (670) 670
disease (665) 665
bacterial infections and mycoses (662) 662
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15785) 15785
Spanish (399) 399
French (214) 214
German (93) 93
Portuguese (93) 93
Japanese (79) 79
Turkish (47) 47
Chinese (34) 34
Russian (28) 28
Danish (22) 22
Italian (18) 18
Polish (11) 11
Hungarian (10) 10
Romanian (9) 9
Hebrew (7) 7
Norwegian (7) 7
Korean (6) 6
Dutch (5) 5
Finnish (4) 4
Croatian (3) 3
Serbian (3) 3
Czech (2) 2
Icelandic (2) 2
Lithuanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical infectious diseases, ISSN 1058-4838, 05/2015, Volume 60, Issue 9, pp. 1319 - 1325
...) bacteremia is controversial. We compared 14-day mortality of PTZ vs carbapenems as empiric therapy in a cohort of patients with ESBL bacteremia who all received definitive therapy with a carbapenem. Methods... 
Resistance | ESBL | Carbapenem | Piperacillin-tazobactam | Gram-negative | MORTALITY | INFECTIOUS DISEASES | HOSPITALIZED-PATIENTS | RISK-FACTORS | gram-negative | KLEBSIELLA-PNEUMONIAE BACTEREMIA | ANTIMICROBIAL THERAPY | ESCHERICHIA-COLI | MICROBIOLOGY | IMMUNOLOGY | INHIBITOR COMBINATIONS | resistance | carbapenem | INTENSIVE-CARE-UNIT | piperacillin-tazobactam | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Bacteremia - mortality | Male | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Time Factors | Penicillanic Acid - therapeutic use | Female | beta-Lactamases - metabolism | Penicillanic Acid - analogs & derivatives | Klebsiella oxytoca - drug effects | Enterobacteriaceae Infections - microbiology | Bacteremia - drug therapy | Enterobacteriaceae Infections - mortality | Proportional Hazards Models | Survival Rate | Klebsiella oxytoca - isolation & purification | Proteus mirabilis - isolation & purification | Propensity Score | Carbapenems - therapeutic use | Escherichia coli - isolation & purification | beta-Lactamase Inhibitors - therapeutic use | Aged | Proteus mirabilis - drug effects | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Piperacillin - therapeutic use | Care and treatment | Dosage and administration | Tazobactam | Carbapenems | Piperacillin | Bacteremia | and Commentaries
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2014, Volume 111, Issue 40, pp. 14494 - 14499
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2009, Volume 35, Issue 4, pp. 375 - 381
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2012, Volume 55, Issue 7, pp. 943 - 950
Journal Article
by Gutiérrez-Gutiérrez, Belén and Salamanca, Elena and de Cueto, Marina and Hsueh, Po-Ren and Viale, Pierluigi and Paño-Pardo, José Ramón and Venditti, Mario and Tumbarello, Mario and Daikos, George and Cantón, Rafael and Doi, Yohei and Tuon, Felipe Francisco and Karaiskos, Ilias and Pérez-Nadales, Elena and Schwaber, Mitchell J and Azap, Özlem Kurt and Souli, Maria and Roilides, Emmanuel and Pournaras, Spyros and Akova, Murat and Pérez, Federico and Bermejo, Joaquín and Oliver, Antonio and Almela, Manel and Lowman, Warren and Almirante, Benito and Bonomo, Robert A and Carmeli, Yehuda and Paterson, David L and Pascual, Alvaro and Rodríguez-Baño, Jesús and del Toro, M D and Gálvez, J and Falcone, M and Russo, A and Giamarellou, H and Trecarichi, E M and Losito, A R and García-Vázquez, E and Hernández, A and Gómez, J and Bou, G and Iosifidis, E and Prim, N and Navarro, F and Mirelis, B and Skiada, A and Origüen, J and Juan, R San and Fernández-Ruiz, M and Larrosa, N and Puig-Asensio, M and Cisneros, J M and Molina, J and González, V and Rucci, V and de Gopegui, E Ruiz and Marinescu, C I and Martínez-Martínez, L and Fariñas, M C and Cano, M E and Gozalo, M and Mora-Rillo, M and Francisco, C Navarro-San and Peña, C and Gómez-Zorrilla, S and Tubau, F and Tsakris, A and Zarkotou, O and Antoniadou, A and Poulakou, G and Pitout, J and Virmani, D and Torre-Cisneros, J and Guzmán-Puche, J and Helvaci, Ö and Sahin, A O and Pintado, V and Ruiz, P and Bartoletti, M and Giannella, M and Tacconelli, E and Riemenschneider, F and Calbo, E and Badia, C and Xercavins, M and Gasch, O and Fontanals, D and Jové, E and REIPI/ESGBIS/INCREMENT Investigators and REIPI ESGBIS INCREMENT
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Journal Article
The Journal of infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
.... Outcomes assessed included time to optimal antibiotic therapy, time to active treatment when inactive, hospital and intensive... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article